FDA
-
-
-
-
-
-
-
Angle PLC: Total Voting Rights and Covington Subscription
-
-
-
-
-
-
-
Seventh Peer Reviewed Publication on Angle's Parsortix(TM) System
-
-
-
-
-
-
-
Angle PLC Announces New Research With Parsortix Demonstrates Ability to Identify Key Proteins Involved in Breast Cancer Cell Growth and Survival
-
-
-
-
-
-
-
Angle PLC: Success With Parsortix in Colorectal Cancer
-
-
-
-
-
-
-
Angle PLC: Interim Results for the six months ended 31 October 2016
-
322,900 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

